Peregrine has developed a complete Anti-PS immunotherapy PLATFORM.
EXOSOMES: Early cancer detection and monitoring,
IMAGING: I-124 PGN650, locating and monitoring cancer tumors including metastases.
BIOMARKERS: Pre-screening prospective cancer patients for treatment success.
ANTI-PS CANCER TREATMENT: Immunotherapy combinations are being explored for enhanced success in cancer treatment.
Peregrine has a full anti-PS platform, and Bavi is being explored in combinations with the downstream immunotherapies, from the pipelines of various BPs, through NCCN and MSK. BP eyes will be focused on anti-PS technology.
Who’s at the table?? We won’t know until we know!!
IMO
sunstar
Market Data 
Markets 
AI
